Cargando…

Monoclonal antibody-based therapies for microbial diseases

The monoclonal antibody (mAb) revolution that currently provides many new options for the treatment of neoplastic and inflammatory diseases has largely bypassed the field of infectious diseases. Only one mAb is licensed for use against an infectious disease, although there are many in various stages...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saylor, Carolyn, Dadachova, Ekaterina, Casadevall, Arturo
Formato:	Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810317/ https://www.ncbi.nlm.nih.gov/pubmed/20006139 http://dx.doi.org/10.1016/j.vaccine.2009.09.105

Ejemplares similares

Cryptococcus neoformans as a Model for Radioimmunotherapy of Infections
por: Dadachova, Ekaterina, et al.
Publicado: (2011)

Monoclonal Antibodies and Toxins—A Perspective on Function and Isotype
por: Chow, Siu-Kei, et al.
Publicado: (2012)

Monoclonal antibody therapies against SARS-CoV-2
por: Focosi, Daniele, et al.
Publicado: (2022)

Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line
por: Harris, Matthew, et al.
Publicado: (2011)

A requirement for FcγR in antibody-mediated bacterial toxin neutralization
por: Abboud, Nareen, et al.
Publicado: (2010)

Future Vistas in Alpha Therapy of Infectious Diseases
por: Dadachova, Ekaterina
Publicado: (2019)

A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment
por: Focosi, Daniele, et al.
Publicado: (2022)

SARS-CoV-2 variants resistant to monoclonal antibodies in immunocompromised patients constitute a public health concern
por: Casadevall, Arturo, et al.
Publicado: (2023)

Treating Cancer as an Infectious Disease—Viral Antigens as Novel Targets for Treatment and Potential Prevention of Tumors of Viral Etiology
por: Wang, Xing Guo, et al.
Publicado: (2007)

Quantitative Modeling of Microbial Population Responses to Chronic Irradiation Combined with Other Stressors
por: Shuryak, Igor, et al.
Publicado: (2016)

Potential Use of Radiolabeled Antibodies for Imaging and Treatment of COVID-19
por: Dadachova, Ekaterina
Publicado: (2021)

Microbials for the production of monoclonal antibodies and antibody fragments
por: Spadiut, Oliver, et al.
Publicado: (2014)

The Omicron variant of concern: Diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies
por: Focosi, Daniele, et al.
Publicado: (2022)

Antibody-based therapies for emerging infectious diseases.
por: Casadevall, A
Publicado: (1996)

Targeted Killing of Virally Infected Cells by Radiolabeled Antibodies to Viral Proteins
por: Dadachova, Ekaterina, et al.
Publicado: (2006)

Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer
por: Jiang, Zewei, et al.
Publicado: (2019)

Passive administration of monoclonal antibodies to Anthrolysin O prolong survival in mice lethally infected with Bacillus anthracis
por: Nakouzi, Antonio, et al.
Publicado: (2008)

Monoclonal antibody-based therapies
por: Shima, Midori
Publicado: (2018)

The Ebola Epidemic Crystallizes the Potential of Passive Antibody Therapy for Infectious Diseases
por: Casadevall, Arturo, et al.
Publicado: (2015)

Effects of disrupting the polyketide synthase gene WdPKS1 in Wangiella [Exophiala] dermatitidis on melanin production and resistance to killing by antifungal compounds, enzymatic degradation, and extremes in temperature
por: Paolo, William F, et al.
Publicado: (2006)

Pre-Clinical Evaluation of a (213)Bi-Labeled 2556 Antibody to HIV-1 gp41 Glycoprotein in HIV-1 Mouse Models as a Reagent for HIV Eradication
por: Dadachova, Ekaterina, et al.
Publicado: (2012)

Radioimmunotherapy of Fungal Diseases: The Therapeutic Potential of Cytocidal Radiation Delivered by Antibody Targeting Fungal Cell Surface Antigens
por: Nosanchuk, Joshua D., et al.
Publicado: (2012)

The Damage-Response Framework of Microbial Pathogenesis and Infectious Diseases
por: Pirofski, Liise-anne, et al.
Publicado: (2008)

Correction: Pre-Clinical Evaluation of a (213)Bi-Labeled 2556 Antibody to HIV-1 gp41 Glycoprotein in HIV-1 Mouse Models as a Reagent for HIV Eradication
por: Dadachova, Ekaterina, et al.
Publicado: (2012)

The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
por: Casadevall, Arturo, et al.
Publicado: (2021)

On microbial virulence, mammals, and climate change
por: Casadevall, Arturo
Publicado: (2022)

Monoclonal antibody-based therapies for Waldenström's macroglobulinemia
por: Fotiou, Despina, et al.
Publicado: (2022)

Monoclonal Antibody-Based Therapies for Myasthenia Gravis
por: Alabbad, Sawsan, et al.
Publicado: (2020)

Protection of Melanized Cryptococcus neoformans from Lethal Dose Gamma Irradiation Involves Changes in Melanin's Chemical Structure and Paramagnetism
por: Khajo, Abdelahad, et al.
Publicado: (2011)

Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy
por: Casadevall, Arturo, et al.
Publicado: (2020)

Future of Monoclonal Antibody Therapy in Parkinson’s Disease
por: Kharel, Sanjeev, et al.
Publicado: (2022)

Monoclonal antibodies for imaging and therapy.
por: Epenetos, A. A., et al.
Publicado: (1989)

The damage-response framework of microbial pathogenesis
por: Casadevall, Arturo, et al.
Publicado: (2003)

Ionizing Radiation Changes the Electronic Properties of Melanin and Enhances the Growth of Melanized Fungi
por: Dadachova, Ekaterina, et al.
Publicado: (2007)

Monoclonal antibodies for the therapy of cancer
por: Simpson, Andrew, et al.
Publicado: (2014)

Monoclonal Antibodies in Cancer Therapy
por: Zahavi, David, et al.
Publicado: (2020)

Microbial threat lists: obstacles in the quest for biosecurity?
por: Casadevall, Arturo, et al.
Publicado: (2010)

Monoclonal Antibodies Approved for Cancer Therapy
por: Baldo, Brian A.
Publicado: (2016)

Passive Monoclonal and Polyclonal Antibody Therapies
por: Pelletier, J. Peter R., et al.
Publicado: (2020)

Biodistribution of a Radiolabeled Antibody in Mice as an Approach to Evaluating Antibody Pharmacokinetics
por: Allen, Kevin J. H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7d4h4u6201403pvff8g8k1nma2